Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/95824
標題: A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice
作者: Lin, Po-Han
Li, Huei-Ying
Fan, Sheng-Chih
Yuan, Tzu-Hang
Chen, Ming
Hsu, Yu-Hua
Yang, Yu-Hsuan
李龍緣
Li, Long-Yuan
Yeh, Su-Peng
Bai, Li-Yuan
Liao, Yu-Min
Lin, Chen-Yuan
Hsieh, Ching-Yun
Lin, Ching-Chan
Lin, Che-Hung
Lien, Ming-Yu
Chen, Tzu-Ting
Ni, Yen-Hsuan
Chiu, Chang-Fang
關鍵字: Acute myeloid leukemia
gene mutations
next-generation sequencing
precision medicine
prognosis
Adolescent
Adult
Aged
Child
Cytogenetic Analysis
Female
Gene Regulatory Networks
High-Throughput Nucleotide Sequencing
Humans
Leukemia, Myeloid, Acute
Male
Middle Aged
Prognosis
Sequence Analysis, DNA
Survival Analysis
Young Adult
Genetic Predisposition to Disease
Mutation
出版社: CANCER MEDICINE
摘要: Conventional cytogenetics can categorize patients with acute myeloid leukemia (AML) into favorable, intermediate, and unfavorable-risk groups; however, patients with intermediate-risk cytogenetics represent the major population with variable outcomes. Because molecular profiling can assist with AML prognosis and next-generation sequencing allows simultaneous sequencing of many target genes, we analyzed 260 genes in 112 patients with de novo AML who received standard treatment. Multivariate analysis showed that karyotypes and mutation status of TET2, PHF6, KIT, and NPM1mutation /FLT3- internal tandem duplication (ITD)negative were independent prognostic factors for the entire cohort. Among patients with intermediate-risk cytogenetics, patients with mutations in CEBPAdouble mutation , IDH2, and NPM1 in the absence of FLT3-ITD were associated with improved Overall survival (OS), similar to those with favorable-risk cytogenetics; patients with mutations in TET2, RUNX1, ASXL1, and DNMT3A were associated with reduced OS, similar to those with unfavorable-risk cytogenetics. We concluded that integration of cytogenetic and molecular profiling improves prognostic stratification of patients into three groups with more distinct prognoses (P < 0.001) and significantly reduces the number of patients classified as intermediate risk. In addition, our study demonstrates that next-generation sequencing (NGS)-based multi-gene sequencing is clinically applicable in establishing an accurate risk stratification system for guiding therapeutic decisions.
URI: http://hdl.handle.net/11455/95824
文章連結: https://www.ncbi.nlm.nih.gov/pubmed/28070990
Appears in Collections:生命科學系所

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.